[卵巢癌中肿瘤标志物Ca 125与血浆核糖核酸酶的研究经验]
[Experiences with the tumor markers Ca 125 and plasma ribonuclease in ovarian cancer].
作者信息
Lücke R, Benz R, Kraus H
机构信息
Universitäts-Frauenklinik Ulm.
出版信息
Geburtshilfe Frauenheilkd. 1987 Dec;47(12):846-9. doi: 10.1055/s-2008-1036059.
PMID:3481339
Abstract
The tumor markers Ca 125 and serum ribonuclease were determined simultaneously in 35 patients with primary ovarian cancer during therapy and follow-up. In patients with second-look operation, Ca 125 and ribonuclease correlated well with the presence of metastases. In our experience the marker Ca 125 appeared to be superior to serum ribonuclease levels. Recurrence may be detected equally well with both markers.
摘要
在35例原发性卵巢癌患者的治疗及随访过程中，同时测定了肿瘤标志物Ca 125和血清核糖核酸酶。在接受二次探查手术的患者中，Ca 125和核糖核酸酶与转移灶的存在密切相关。根据我们的经验，标志物Ca 125似乎优于血清核糖核酸酶水平。两种标志物对复发的检测效果相当。
相似文献
1
[Experiences with the tumor markers Ca 125 and plasma ribonuclease in ovarian cancer].[卵巢癌中肿瘤标志物Ca 125与血浆核糖核酸酶的研究经验]
Geburtshilfe Frauenheilkd. 1987 Dec;47(12):846-9. doi: 10.1055/s-2008-1036059.
2
[Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer].[卵巢癌二次探查剖腹术时的血清CA 125值及组织学 findings] （此处“findings”未明确，可根据上下文灵活翻译，比如“结果”等）
Geburtshilfe Frauenheilkd. 1988 May;48(5):331-3. doi: 10.1055/s-2008-1035985.
3
[Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].[利用肿瘤标志物CA 125诊断上皮性卵巢癌复发]
Wien Klin Wochenschr. 1987 Nov 6;99(21):768-70.
4
[Tumor marker combination versus second-look operation in ovarian cancer].[卵巢癌中肿瘤标志物组合与二次探查术的比较]
Zentralbl Gynakol. 1990;112(9):561-6.
5
[Predictive value of a tumor marker combination for the monitoring of ovarian cancer].[肿瘤标志物组合对卵巢癌监测的预测价值]
Wien Klin Wochenschr. 1986 May 16;98(10):319-25.
6
Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.卵巢癌治疗前及治疗期间的肿瘤相关抗原Ca 125
Obstet Gynecol. 1986 Apr;67(4):468-72.
7
[Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].肿瘤标志物CA-125对卵巢恶性肿瘤患者术前诊断及术后管理的临床意义
Geburtshilfe Frauenheilkd. 1985 Nov;45(11):769-73. doi: 10.1055/s-2008-1036133.
8
[Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].[关于恶性上皮性卵巢肿瘤的肿瘤标志物CA 125的经验]
Geburtshilfe Frauenheilkd. 1985 Apr;45(4):205-12. doi: 10.1055/s-2008-1036234.
9
[Comparative study of 3 markers in ovarian cancer: CA 125, CA 19,9 and CEA].
J Gynecol Obstet Biol Reprod (Paris). 1986;15(5):609-13.
10
[Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Geburtshilfe Frauenheilkd. 1986 Jan;46(1):1-10. doi: 10.1055/s-2008-1036152.
Zotero 插件